GOVX · GeoVax Labs, Inc. · Earnings Call Transcripts & Audio
$0.46
-0.01 (-2.28%)
At close · Sep 10
Going-concern doubt
— flagged Jul 27, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors collectively raise substantial doubt about the Company’s ability to continue as a going concern. Management believes that we will be successful in securing the additional capital required to continue the Company’s planned operations, but that our plans do not fully alleviate the substantial doubt about the Company’s ability to operate as a going concern.”View the 10-Q filed Jul 27, 2026
Market Cap
$3.43M
Shares
7.37M
GeoVax Labs, Inc. Earnings Call Transcripts
Quarterly earnings calls for GeoVax Labs, Inc. (GOVX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼34.4%
$164,962
−$13.74M
'21 Q4
22-03-10
▼26.2%
$81,526
−$2.43M
'22 Q1
22-05-02
▼100%
$
−$2.24M
'22 Q2
22-08-04
▼100%
$
−$3.97M
'22 Q3
22-11-14
▼100%
$
−$5.38M
'22 Q4
23-03-24
▼100%
$
−$4.04M
'23 Q1
23-05-05
·
$
−$5.93M
'23 Q2
23-08-10
·
$
−$8.41M
'23 Q3
23-11-09
·
$
−$7.59M
'23 Q4
24-03-01
·
$
−$5.85M
'24 Q1
24-05-15
·
$300,677
−$5.06M
'24 Q2
24-08-07
·
$2.79M
−$5.82M
'24 Q3
24-11-13
·
$864,415
−$8.26M
'24 Q4
25-03-28
·
$1.64M
−$5.36M
'25 Q1
25-05-01
▲183.5%
$852,282
−$5.37M
'25 Q2
25-07-28
LATEST
▼100%
$
−$6.32M
'25 Q3
25-11-13
Capital Markets Day
Investor event
2026-05-28
GeoVax Labs, Inc. (GOVX) May 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-13
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript
Confident tone
GEO-MVA Mpox/Smallpox vaccine and EMA expedited path
Gedeptin oncology program and KEYNOTE-689
Partnering, collaboration and non-dilutive funding interest
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-28
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript
Confident tone
GEO-MVA mpox/smallpox vaccine
GEO-CM04S1 COVID-19 vaccine for immunocompromised
Gedeptin in head and neck cancer
Revenue
$852,282
▲ 183.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript
Positive tone
GEO-CM04S1 COVID-19 vaccine for immunocompromised patients
BARDA Project NextGen contract termination
Gedeptin cancer therapy
Revenue
$1.64M
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-28
GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call
Revenue
$864,415*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript
Confident tone
GEO-CM04S1 COVID-19 Vaccine
BARDA Project NextGen Award
Gedeptin Oncology Program
Revenue
$2.79M
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call
Revenue
$300,677
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript
Positive tone
CM04S1 COVID-19 vaccine
Gedeptin Phase II head and neck cancer
Immunocompromised patient focus
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-01
GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript
Positive tone
Project NextGen / BARDA award
Gedeptin (advanced head and neck cancer)
GEO-CM04S1 COVID-19 vaccine (mRNA booster)
Revenue
$*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
GeoVax Labs, Inc. (GOVX) Q2 2023 Earnings Call Transcript
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
GeoVax Labs, Inc. (GOVX) Q1 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-24
GeoVax Labs, Inc. (GOVX) Q4 2022 Earnings Call Transcript
Revenue
$*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
GeoVax Labs, Inc. (GOVX) Q3 2022 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
GeoVax Labs, Inc. (GOVX) Q2 2022 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
GeoVax Labs, Inc. (GOVX) Q1 2022 Earnings Call Transcript
Revenue
$81,526
▼ 26.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
GeoVax Labs, Inc. (GOVX) Q4 2021 Earnings Call Transcript
Revenue
$164,962*
▼ 34.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
GeoVax Labs, Inc. (GOVX) Q3 2021 Earnings Call Transcript
Revenue
$30,414
▼ 92.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
GeoVax Labs, Inc. (GOVX) Q2 2021 Earnings Call Transcript
Revenue
$79,708
▼ 81.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
GeoVax Labs, Inc. (GOVX) Q1 2021 Earnings Call Transcript
Revenue
$110,417
▼ 84.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-23
GeoVax Labs, Inc. (GOVX) Q4 2020 Earnings Call Transcript
Revenue
$251,621*
▼ 6.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
GeoVax Labs, Inc. (GOVX) Q3 2020 Earnings Call Transcript
Revenue
$415,458
▲ 24.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 earnings calls